Gu Y - Search Results

1

[Association between polymorphisms of ERCC1 and response in patients with advanced non-small cell lung cancer receiving cisplatin-based chemotherapy].

Wang J, Zhang Q, Zhang H, Wang Q, Yang X, Gu Y, Zhang S. Wang J, et al. Among authors: gu y. Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):337-41. doi: 10.3779/j.issn.1009-3419.2010.04.13. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20677561 Free PMC article. Chinese.

2

[Comprehensive evaluation of treatment outcome of various therapies in 508 cases of small cell lung cancer].

Zhang Y, Gu YF, Deng LH, Yang SS, Li SY. Zhang Y, et al. Among authors: gu yf. Zhonghua Yi Xue Za Zhi. 2004 Jun 2;84(11):917-9. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15329278 Chinese. No abstract available.

3

[Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].

Gu YF, Zhang ZD, Zhang SC, Zheng SH, Jia HY, Gu SX. Gu YF, et al. Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3064-8. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18261353 Chinese.

4

[A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer.].

Zhang S, Wang J, Wang Q, Yang X, Hu F, Li X, Gu Y, Wang H. Zhang S, et al. Among authors: gu y. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):110-4. doi: 10.3779/j.issn.1009-3419.2008.01.024. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727278 Free article. Chinese.

5

[The relationship between genetic polymorphism of GSTM1 and the outcome of chemotherapy in Chinese patients with primary lung cancer.].

Li W, Gu Y, Lai B, Wang H. Li W, et al. Among authors: gu y. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):130-6. doi: 10.3779/j.issn.1009-3419.2009.12.28. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727282 Free article. Chinese.

6

Expression of ERCC1 and class III ß-tubulin in resected non-small cell lung cancer and its correlation with platinum-based adjuvant chemotherapy.

Zhang S, Li Q, Zhang Q, Wang J, Zhang H, Zhang Z, Wang Q, Yang X, Gu Y, Zhang H. Zhang S, et al. Among authors: gu y. Int J Biol Markers. 2010 Jul-Sep;25(3):141-9. doi: 10.1177/172460081002500304. Int J Biol Markers. 2010. PMID: 20878620 Free article.

7

[Frequency of CYP2A6 gene deletion and its relation to risk of lung cancer].

Gu Y, Zhang S, Lai B, Zhan X, Zhang Y. Gu Y, et al. Zhongguo Fei Ai Za Zhi. 2005 Aug 20;8(4):297-9. doi: 10.3779/j.issn.1009-3419.2005.04.09. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21108885 Free article. Chinese.

8

[A randomized study comparing topotecan plus cisplatin versus etoposide plus carboplatin for previously untreated small cell lung cancer].

Zhang S, Wang J, Wang Q, Zhang H, Hu F, Yang X, Fan X, Wang H, Gu Y, Li X. Zhang S, et al. Among authors: gu y. Zhongguo Fei Ai Za Zhi. 2007 Apr 20;10(2):144-7. doi: 10.3779/j.issn.1009-3419.2007.02.15. Zhongguo Fei Ai Za Zhi. 2007. PMID: 21114940 Free article. Chinese.

9

[Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility].

Gu Y, Zhang S, Lai B, Wang H, Zhan X. Gu Y, et al. Zhongguo Fei Ai Za Zhi. 2004 Apr 20;7(2):112-7. doi: 10.3779/j.issn.1009-3419.2004.02.08. Zhongguo Fei Ai Za Zhi. 2004. PMID: 21215003 Free article. Chinese.

10

[Clinical study of combined chemotherapy of domestic paclitaxel and vinorelbine plus platinum for advanced non-small cell lung cancer].

Zhang S, Yang X, Hu F, Wang Q, Fan X, Wang J, Gu Y, Wang H, Zhang H, Li X. Zhang S, et al. Among authors: gu y. Zhongguo Fei Ai Za Zhi. 2004 Jun 20;7(3):236-9. doi: 10.3779/j.issn.1009-3419.2004.03.13. Zhongguo Fei Ai Za Zhi. 2004. PMID: 21232226 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,721 results

Search Page

Filters